Back
Matinas BioPharma Holdings Stock Price Chart
Sponsored
MTNB
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
22
MTNB
Matinas BioPharma Holdings
Last Price:
$0.54
Seasonality Move:
13.52%
7 Day Trial
ALL ACCESS PASS
$
7
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing slight buying pressure.
Matinas BioPharma Holdings Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.57 | Sell |
20-day SMA: | 0.59 | Sell |
50-day SMA: | 1.38 | Sell |
200-day SMA: | 6.37 | Sell |
8-day EMA: | 0.57 | Sell |
20-day EMA: | 0.66 | Sell |
50-day EMA: | 1.42 | Sell |
200-day EMA: | 5.65 | Sell |
Matinas BioPharma Holdings Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 31.02 | Sell |
Chaikin Money Flow: | -19914 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.56 - 0.62) | Sell |
Bollinger Bands (100): | (0.8 - 5.42) | Sell |
Matinas BioPharma Holdings Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Matinas BioPharma Holdings Stock
Is Matinas BioPharma Holdings Stock a Buy?
-
Matinas BioPharma Holdings share price is 0.55 while MTNB 8-day simple moving average is 0.57, which is a Sell signal.
-
The stock price of MTNB is 0.55 while Matinas BioPharma Holdings 20-day SMA is 0.59, which makes it a Sell.
-
Matinas BioPharma Holdings 50-day simple moving average is 1.38 while MTNB share price is 0.55, making it a Sell technically.
-
MTNB stock price is 0.55 and Matinas BioPharma Holdings 200-day simple moving average is 6.37, creating a Sell signal.
MTNB Technical Analysis vs Fundamental Analysis
Sell
22
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy or a Sell?
-
Matinas BioPharma Holdings stock is rated a SellThe current Matinas BioPharma Holdings [MTNB] share price is $0.55. The Score for MTNB is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Matinas BioPharma Holdings Stock Info
Market Cap:
2.8M
Price in USD:
0.55
Share Volume:
63.4K
Matinas BioPharma Holdings 52-Week Range
52-Week High:
21.50
52-Week Low:
0.50
Sell
22
Matinas BioPharma Holdings (MTNB)
is a Sell
Matinas BioPharma Holdings Share Price Forecast
-
What is the Matinas BioPharma Holdings stock price today?The Matinas BioPharma Holdings stock price is 0.55 USD today.
-
Will MTNB stock go up or go down?Matinas BioPharma Holdings> share price is forecast to RISE/FALL based on technical indicators
-
Is Matinas BioPharma Holdings overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Matinas BioPharma Holdings is overvalued.
Is Matinas BioPharma Holdings Stock a Buy?
-
Matinas BioPharma Holdings share price is 0.55 while MTNB 8-day exponential moving average is 0.57, which is a Sell signal.
-
The stock price of MTNB is 0.55 while Matinas BioPharma Holdings 20-day EMA is 0.66, which makes it a Sell.
-
Matinas BioPharma Holdings 50-day exponential moving average is 1.42 while MTNB share price is 0.55, making it a Sell technically.
-
MTNB stock price is 0.55 and Matinas BioPharma Holdings 200-day simple moving average is 5.65, creating a Sell signal.
Fundamental Analysis of Matinas BioPharma Holdings
Is Matinas BioPharma Holdings a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $1.06 per share.
Technical Analysis of Matinas BioPharma Holdings
Should I short Matinas BioPharma Holdings stock?
-
MTNB Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting Matinas BioPharma Holdings is a Sell
-
Matinas BioPharma Holdings Relative Strength Index (RSI) is 31.02, which suggest Matinas BioPharma Holdings is oversold
-
The Bollinger Bands (25) for Matinas BioPharma Holdings is (0.56 - 0.62), which suggest Matinas BioPharma Holdings is a Sell
-
The Bollinger Bands (100) for Matinas BioPharma Holdings is (0.8 - 5.42), which suggest Matinas BioPharma Holdings is a Sell
* Matinas BioPharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.